创新药概念再度拉升 皓元医药涨超15%

Core Viewpoint - The innovative drug concept has seen a resurgence, with Haoyuan Pharmaceutical rising over 15%, and both Kangchen Pharmaceutical and Huahai Pharmaceutical hitting the daily limit up [1] Company Summary - Haoyuan Pharmaceutical experienced a significant increase in stock price, rising more than 15% [1] - Kangchen Pharmaceutical and Huahai Pharmaceutical both reached the daily trading limit, indicating strong market interest and investor confidence [1] Industry Summary - The innovative drug sector is witnessing renewed interest, reflected in the substantial stock price movements of key players [1]